Analysis and Commentary STEVEN GROSSMAN 3/29/19 Analysis and Commentary STEVEN GROSSMAN 3/29/19 What Chairman Hoeven Said, and Why Read More Advocacy at a Glance STEVEN GROSSMAN 7/13/18 Advocacy at a Glance STEVEN GROSSMAN 7/13/18 Timing of Ag/FDA Appropriations Bills Still TBD Read More Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Ever Wonder What FDA Was Like A Decade Ago and more Read More
Analysis and Commentary STEVEN GROSSMAN 3/29/19 Analysis and Commentary STEVEN GROSSMAN 3/29/19 What Chairman Hoeven Said, and Why Read More
Advocacy at a Glance STEVEN GROSSMAN 7/13/18 Advocacy at a Glance STEVEN GROSSMAN 7/13/18 Timing of Ag/FDA Appropriations Bills Still TBD Read More
Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Ever Wonder What FDA Was Like A Decade Ago and more Read More
